XML 38 R24.htm IDEA: XBRL DOCUMENT v3.19.2
FINANCIAL INSTRUMENTS (Tables)
6 Months Ended
Jun. 30, 2019
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Marketable Securities
At June 30, 2019 and December 31, 2018, the fair value of marketable securities are as follows:
 
June 30, 2019
 
December 31, 2018
 
(In thousands)
Marketable equity securities
$
161,749

 
$
419

Available-for-sale marketable debt securities

 
123,246

     Total marketable securities
$
161,749

 
$
123,665


Schedule of Current Available-for-sale Marketable Securities
At December 31, 2018, current available-for-sale marketable debt securities were as follows:
 
Amortized
Cost
 
Gross
Unrealized
Gains
 
Gross
Unrealized
Losses
 
Fair Value
 
(In thousands)
Treasury discount notes
$
112,291

 
$
3

 
$
(3
)
 
$
112,291

Commercial paper
10,955

 

 

 
10,955

Total available-for-sale marketable debt securities
$
123,246

 
$
3

 
$
(3
)
 
$
123,246


Schedule of Proceeds from Maturities and Sales of Available-for-sale Marketable Debt Securities
The following table presents the proceeds from maturities of available-for-sale marketable debt securities:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
 
(In thousands)
Proceeds from maturities of available-for-sale marketable debt securities
$
40,000

 
$
5,000

 
$
163,500

 
$
10,000


Schedule of Realized and Unrealized Gains and Losses
The following table presents a summary of realized and unrealized gains and losses recorded in other income (expense), net, as adjustments to the carrying value of equity securities without readily determinable fair values held as of June 30, 2019 and 2018.
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
 
(In thousands)
Upward adjustments (gross unrealized gains)
$

 
$
128,786

 
$

 
$
128,786

Downward adjustments including impairment (gross unrealized losses)
(500
)
 
(2,396
)
 
(650
)
 
(2,588
)
Total
$
(500
)
 
$
126,390

 
$
(650
)
 
$
126,198


Realized and unrealized gains and losses for the Company's marketable equity securities and investments without readily determinable fair values for the three and six months ended June 30, 2019 and 2018 are as follows:
 
Three Months Ended June 30,
 
Six Months Ended June 30,
 
2019
 
2018
 
2019
 
2018
 
(In thousands)
Realized gains, net, for equity securities sold
$
2,066

 
$
27,275

 
$
2,144

 
$
27,172

Unrealized gains, net, on equity securities held
29,369

 
126,414

 
29,247

 
126,559

Total gains recognized, net, in other income, net
$
31,435

 
$
153,689

 
$
31,391

 
$
153,731


Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis
The following tables present the Company's financial instruments that are measured at fair value on a recurring basis:
 
June 30, 2019
 
Quoted Market
Prices in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Total
Fair Value
Measurements
 
(In thousands)
Assets:
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
1,754,220

 
$

 
$

 
$
1,754,220

Treasury discount notes

 
711,877

 

 
711,877

Time deposits

 
145,036

 

 
145,036

Commercial paper

 
30,956

 

 
30,956

Marketable securities:
 
 
 
 
 
 
 
Marketable equity security
161,749

 

 

 
161,749

Total
$
1,915,969

 
$
887,869

 
$

 
$
2,803,838

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
Contingent consideration arrangement
$

 
$

 
$
(29,803
)
 
$
(29,803
)
 
December 31, 2018
 
Quoted Market
Prices in Active
Markets for
Identical Assets
(Level 1)
 
Significant
Other
Observable
Inputs
(Level 2)
 
Significant
Unobservable
Inputs
(Level 3)
 
Total
Fair Value
Measurements
 
(In thousands)
Assets:
 
 
 
 
 
 
 
Cash equivalents:
 
 
 
 
 
 
 
Money market funds
$
880,815

 
$

 
$

 
$
880,815

Treasury discount notes

 
561,733

 

 
561,733

Commercial paper

 
162,417

 

 
162,417

Time deposits

 
90,036

 

 
90,036

Marketable securities:
 
 
 
 
 
 
 
  Treasury discount notes

 
112,291

 

 
112,291

  Commercial paper

 
10,955

 

 
10,955

Marketable equity security
419

 

 

 
419

Total
$
881,234

 
$
937,432

 
$

 
$
1,818,666

 
 
 
 
 
 
 
 
Liabilities:
 
 
 
 
 
 
 
Contingent consideration arrangements
$

 
$

 
$
(28,631
)
 
$
(28,631
)

Schedule of Changes in Liabilities Measured at Fair Value on a Recurring Basis Using Significant Unobservable Inputs (Level 3)
The Company's financial instruments that are measured at fair value on a recurring basis using significant unobservable inputs (Level 3) are its contingent consideration arrangements.
 
Contingent Consideration Arrangements
 
Three Months Ended June 30,
 
2019
 
2018
 
(In thousands)
Balance at April 1
$
(28,186
)
 
$
(1,965
)
Total net (losses) gains:
 
 
 
Included in earnings:
 
 
 
Fair value adjustments
(1,617
)
 
(54
)
Included in other comprehensive income

 
109

Balance at June 30
$
(29,803
)
 
$
(1,910
)


 
Contingent Consideration Arrangements
 
Six Months Ended June 30,
 
2019
 
2018
 
(In thousands)
Balance at January 1
$
(28,631
)
 
$
(2,647
)
Total net losses:
 
 
 
Included in earnings:
 
 
 
Fair value adjustments
(3,146
)
 
(210
)
Included in other comprehensive loss
(14
)
 
(1
)
Settlements
1,988

 
948

Balance at June 30
$
(29,803
)
 
$
(1,910
)

Schedule of Carrying Value and the Fair Value of Financial Instruments Measured at Fair Value Only for Disclosure Purposes
The following table presents the carrying value and the fair value of financial instruments measured at fair value only for disclosure purposes:
 
June 30, 2019
 
December 31, 2018
 
Carrying
Value
 
Fair
Value
 
Carrying
Value
 
Fair
Value
 
(In thousands)
Current portion of long-term debt
$
(13,750
)
 
$
(13,681
)
 
$
(13,750
)
 
$
(12,753
)
Long-term debt, net(a)
(3,138,531
)
 
(3,914,422
)
 
(2,245,548
)
 
(2,460,204
)

_____________________
(a) 
At June 30, 2019 and December 31, 2018, the carrying value of long-term debt, net includes unamortized original issue discount and debt issuance costs of $429.1 million and $88.9 million, respectively.